HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Mitsiades Selected Research

Medullary Carcinoma

8/2000Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Mitsiades Research Topics

Disease

8Neoplasms (Cancer)
01/2016 - 01/2001
4Multiple Myeloma
03/2004 - 05/2001
3Thyroid Neoplasms (Thyroid Cancer)
08/2003 - 08/2000
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2016 - 06/2001
2Ewing Sarcoma (Sarcoma, Ewing)
08/2001 - 03/2001
2Neuroblastoma
06/2001 - 05/2001
2Graves Disease (Basedow Disease)
09/2000 - 07/2000
1Prostatic Intraepithelial Neoplasia
01/2017
1Adenocarcinoma
01/2017
1Disease Progression
01/2016
1Thyroiditis
11/2001
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
05/2001
1Paraproteinemias (Monoclonal Gammopathy)
05/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2001
1Thyroid Diseases (Thyroid Disease)
09/2000
1Papillary Thyroid Cancer
09/2000
1Medullary Carcinoma
08/2000
1Carcinoma (Carcinomatosis)
08/2000
1Papillary Carcinoma
08/2000
1Inflammation (Inflammations)
01/2000

Drug/Important Bio-Agent (IBA)

4LigandsIBA
08/2003 - 08/2000
4Fas Ligand Protein (Fas Ligand)IBA
06/2001 - 07/2000
3Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2003 - 08/2000
3Doxorubicin (Adriamycin)FDA LinkGeneric
08/2001 - 01/2001
2Androgen Receptors (Androgen Receptor)IBA
01/2020 - 01/2016
2fas Receptor (CD95 Antigen)IBA
11/2001 - 06/2001
2Pharmaceutical PreparationsIBA
06/2001 - 01/2001
2Caspase 8 (Caspase-8)IBA
06/2001 - 08/2000
2CaspasesIBA
06/2001 - 08/2000
2Matrix Metalloproteinases (MMPs)IBA
06/2001 - 01/2001
1GlucocorticoidsIBA
01/2020
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1TOR Serine-Threonine KinasesIBA
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1Proteasome InhibitorsIBA
03/2004
1Bortezomib (Velcade)FDA Link
03/2004
12-MethoxyestradiolIBA
03/2004
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2004
1CytokinesIBA
08/2003
1SteroidsIBA
08/2001
1Cytochromes c (Cytochrome c)IBA
06/2001
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
06/2001
1Antisense OligonucleotidesIBA
06/2001
1DNA (Deoxyribonucleic Acid)IBA
06/2001
1Cytotoxins (Cytolysins)IBA
06/2001
1Antineoplastic Agents (Antineoplastics)IBA
06/2001
1Muscarinic AgonistsIBA
05/2001
1Acetylcholine (Acetylcholine Chloride)FDA Link
05/2001
1GTP-Binding Proteins (G-Protein)IBA
05/2001
1Carbachol (Carbastat)FDA Link
05/2001
1AntigensIBA
05/2001
1Complement System Proteins (Complement)IBA
05/2001
1Rituximab (Mabthera)FDA Link
05/2001
1Monoclonal AntibodiesIBA
05/2001
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
03/2001
1Complementary DNA (cDNA)IBA
01/2001
1AntibodiesIBA
09/2000
1Low Density Lipoprotein Receptor-Related Protein-2IBA
09/2000
1Cycloheximide (Cicloheximide)IBA
08/2000
1Protein Synthesis InhibitorsIBA
08/2000
1Indicators and Reagents (Reagents)IBA
08/2000
1Caspase 10IBA
08/2000
1IodidesIBA
07/2000
1AutoantibodiesIBA
07/2000
1NF-kappa B (NF-kB)IBA
01/2000
1CarrageenanIBA
01/2000
1caffeic acid phenethyl esterIBA
01/2000

Therapy/Procedure

5Therapeutics
03/2004 - 05/2001
3Drug Therapy (Chemotherapy)
08/2001 - 01/2001
1Biological Therapy
08/2001